Immunomedics names new CMO
This article was originally published in Scrip
Immunomedics, a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer, autoimmune disorders and other serious diseases, has named Dr Francois Wilhelm chief medical officer. Prior to joining Morris Plains, New Jersey-based Immunomedics, Dr Wilhelm was chief medical officer and senior vice-president of Onconova Therapeutics.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.